Management of Bacterial and Fungal Infections in the ICU: Diagnosis, Treatment, and Prevention Recommendations
暂无分享,去创建一个
[1] T. Rawson,et al. Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design , 2023, Clinical Microbiology and Infection.
[2] K. Klouche,et al. Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial , 2023, Clinical Microbiology and Infection.
[3] G. Guyatt,et al. Association Between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis. , 2022, JAMA.
[4] A. Gordon,et al. Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial. , 2022, JAMA.
[5] M. Girardis,et al. Source control in the management of sepsis and septic shock , 2022, Intensive Care Medicine.
[6] D. Seidel,et al. COVID-19-associated fungal infections , 2022, Nature Microbiology.
[7] A. Christensen,et al. Impact of a Laboratory-Developed Phenotypic Rapid Susceptibility Test Directly From Positive Blood Cultures on Time to Narrowest Effective Therapy in Patients With Gram-Negative Bacteremia: A Prospective Randomized Trial , 2022, Open forum infectious diseases.
[8] M. Boermeester,et al. Perioperative care bundles for the prevention of surgical-site infections: meta-analysis , 2022, The British journal of surgery.
[9] M. Rupp,et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update , 2022, Infection Control & Hospital Epidemiology.
[10] B. Zwaan,et al. Tackling the emerging threat of antifungal resistance to human health , 2022, Nature reviews. Microbiology.
[11] A. Oliver,et al. Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain. , 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[12] D. Pittet,et al. Impact of environmental hygiene interventions on healthcare-associated infections and patient colonization: a systematic review , 2022, Antimicrobial resistance and infection control.
[13] P. Schlattmann,et al. Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial , 2022, Intensive Care Medicine.
[14] F. Youssef,et al. 802. Corynebacterium striatum Outbreak Among Ventilated COVID-19 Patients in an Acute Care Hospital – California, 2021 , 2021, Open Forum Infectious Diseases.
[15] M. Kollef,et al. Timing of antibiotic therapy in the ICU , 2021, Critical Care.
[16] C. Sprung,et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 , 2021, Intensive Care Medicine.
[17] Joseph M. Galante,et al. WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections , 2021, World Journal of Emergency Surgery.
[18] Philip R. O. Payne,et al. Comparison of early warning scores for sepsis early identification and prediction in the general ward setting , 2021, JAMIA open.
[19] P. Georgiou,et al. Optimizing antimicrobial use: challenges, advances and opportunities , 2021, Nature Reviews Microbiology.
[20] A. Irwin,et al. New Microbiological Techniques for the Diagnosis of Bacterial Infections and Sepsis in ICU Including Point of Care , 2021, Current Infectious Disease Reports.
[21] M. Hoenigl,et al. Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches , 2021, Mycoses.
[22] P. Woo,et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. , 2021, The Lancet. Infectious diseases.
[23] H. Sakata,et al. The JAID/JSC guidelines for management of infectious diseases 2017 - Sepsis and catheter-related bloodstream infection. , 2021, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[24] Karsten M. Borgwardt,et al. Early Prediction of Sepsis in the ICU Using Machine Learning: A Systematic Review , 2020, Frontiers in Medicine.
[25] E. Balman,et al. National Institute for Health and Care Excellence (NICE) , 2017, The Grants Register 2022.
[26] OUP accepted manuscript , 2021, Journal of Antimicrobial Chemotherapy.
[27] J. Timsit,et al. Molecular diagnostic methods for pneumonia: how can they be applied in practice? , 2020, Current opinion in infectious diseases.
[28] J. Perfect,et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance , 2020, The Lancet Infectious Diseases.
[29] A. Holmes,et al. Understanding the role of bacterial and fungal infection in COVID-19 , 2020, Clinical Microbiology and Infection.
[30] O. Pajot,et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU , 2020, Annals of Intensive Care.
[31] Anita Løvås Brekken,et al. EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories , 2020, The Journal of antimicrobial chemotherapy.
[32] O. Laitinen,et al. Modern Tools for Rapid Diagnostics of Antimicrobial Resistance , 2020, Frontiers in Cellular and Infection Microbiology.
[33] Kailiang Xu,et al. Risk Factors of Multidrug-Resistant Bacteria in Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis , 2020, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.
[34] Russell E. Lewis,et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion , 2020, Intensive Care Medicine.
[35] A. Holmes,et al. Antimicrobial use, drug-resistant infections and COVID-19 , 2020, Nature Reviews Microbiology.
[36] A. Gayet-Ageron,et al. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial. , 2020, JAMA.
[37] F. Davies,et al. COVID-19 and the potential long-term impact on antimicrobial resistance , 2020, The Journal of antimicrobial chemotherapy.
[38] M. Holubar,et al. Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study , 2020, Journal of Clinical Microbiology.
[39] D. Marriott,et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# , 2020, Intensive Care Medicine.
[40] Fang Zhang,et al. Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use , 2020, JAMA network open.
[41] Y. Mehta,et al. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. , 2020, JAMA.
[42] A. Christe,et al. Risk factors for candidemia: a prospective matched case-control study , 2020, Critical Care.
[43] Philip Smith,et al. Fluconazole‐resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa , 2020, Mycoses.
[44] B. Milošević,et al. Hospital-acquired infections in the adult intensive care unit-Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality. , 2020, American journal of infection control.
[45] A. van Belkum,et al. Innovative and rapid antimicrobial susceptibility testing systems , 2020, Nature Reviews Microbiology.
[46] J. Berman,et al. Drug resistance and tolerance in fungi , 2020, Nature Reviews Microbiology.
[47] G. Kahlmeter,et al. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles , 2020, The Journal of antimicrobial chemotherapy.
[48] J. Timsit,et al. Bloodstream infections in critically ill patients: an expert statement , 2020, Intensive Care Medicine.
[49] D. Gould,et al. Modelling the annual NHS costs and outcomes attributable to healthcare-associated infections in England , 2020, BMJ Open.
[50] W. Meyer,et al. A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready? , 2020, Frontiers in Microbiology.
[51] M. Singer,et al. Sepsis hysteria: excess hype and unrealistic expectations , 2019, The Lancet.
[52] P. White,et al. Pneumocystis jirovecii Pneumonia: Epidemiology, Clinical Manifestation and Diagnosis , 2019, Current Fungal Infection Reports.
[53] M. Ghannoum,et al. Resistance of Candida to azoles and echinocandins worldwide. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[54] B. Cao,et al. Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition). , 2019, Journal of thoracic disease.
[55] J. Powers,et al. Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults: A Systematic Review and Meta-analysis. , 2019, Chest.
[56] Y. Zhong,et al. Risk Factors of Ventilator-Associated Pneumonia in Critically III Patients , 2019, Front. Pharmacol..
[57] Seungkyung Park,et al. Current and Emerging Methods of Antibiotic Susceptibility Testing , 2019, Diagnostics.
[58] P. Mathur,et al. Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India , 2019, The Journal of antimicrobial chemotherapy.
[59] N. Damani. Surveillance and outbreak management , 2019, Manual of Infection Prevention and Control.
[60] B. Wickes,et al. Molecular diagnostics in medical mycology , 2018, Nature Communications.
[61] M. Boermeester,et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections , 2018, World Journal of Emergency Surgery.
[62] W. Dunne,et al. Developmental roadmap for antimicrobial susceptibility testing systems , 2018, Nature Reviews Microbiology.
[63] S. Lockhart,et al. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. , 2018, The Lancet. Infectious diseases.
[64] A. Walker,et al. A Candida auris Outbreak and Its Control in an Intensive Care Setting , 2018, The New England journal of medicine.
[65] G. Maartens,et al. Erratum to South African guideline for the management of community-acquired pneumonia in adults. , 2018, Journal of thoracic disease.
[66] P. Georgiou,et al. Exploring the Use of C-Reactive Protein to Estimate the Pharmacodynamics of Vancomycin , 2018, Therapeutic drug monitoring.
[67] B. Kullberg,et al. Invasive Candidiasis. , 2019, The New England journal of medicine.
[68] C. Clancy,et al. Diagnosing Invasive Candidiasis , 2018, Journal of Clinical Microbiology.
[69] M. Poljak,et al. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance , 2018, Intensive Care Medicine.
[70] T. A. Gray,et al. The effects of care bundles on patient outcomes: a systematic review and meta-analysis , 2017, Implementation Science.
[71] R. Trevethan,et al. Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice , 2017, Front. Public Health.
[72] R. Wunderink,et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia , 2017, European Respiratory Journal.
[73] David Baur,et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. , 2017, The Lancet. Infectious diseases.
[74] S. Marsch,et al. Impact of MALDI-TOF-MS-based identification directly from positive blood cultures on patient management: a controlled clinical trial. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[75] M. Rosengart,et al. The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection. , 2017, Surgical infections.
[76] E. Mylonakis,et al. The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[77] M. Egger,et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations , 2017, Antimicrobial Resistance & Infection Control.
[78] Sarah K. Parker,et al. Implementation of Rapid Molecular Infectious Disease Diagnostics: the Role of Diagnostic and Antimicrobial Stewardship , 2016, Journal of Clinical Microbiology.
[79] Pantelis Georgiou,et al. Mapping the decision pathways of acute infection management in secondary care among UK medical physicians: a qualitative study , 2016, BMC Medicine.
[80] C. Thomson,et al. Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia. , 2016, Annals of the American Thoracic Society.
[81] M. Neely,et al. Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy. , 2016, The Journal of antimicrobial chemotherapy.
[82] Matthew Fisher,et al. First hospital outbreak of the globally emerging Candida auris in a European hospital , 2016, Antimicrobial Resistance & Infection Control.
[83] M. Siegemund,et al. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal. , 2016, Swiss medical weekly.
[84] R. Bellomo,et al. Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials. , 2016, American journal of respiratory and critical care medicine.
[85] L. Lagunes,et al. Current understanding in source control management in septic shock patients: a review. , 2016, Annals of translational medicine.
[86] R. Moraes,et al. De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients: an observational study , 2016, Revista Brasileira de terapia intensiva.
[87] Peggy Cruse,et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[88] A. Cheng,et al. Risk factors associated with urinary tract infections in intensive care patients , 2016 .
[89] Pierre Tattevin,et al. How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State-of-the Art , 2016, Front. Microbiol..
[90] P. Wilson,et al. The Intensive Care Society recommended bundle of interventions for the prevention of ventilator-associated pneumonia , 2016, Journal of the Intensive Care Society.
[91] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[92] A. Holmes,et al. Plasmid-mediated colistin resistance mechanisms: is it time to revise our approach to selective digestive decontamination? , 2016, The Lancet. Infectious diseases.
[93] M. Neely,et al. Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy , 2016, Antimicrobial Agents and Chemotherapy.
[94] M. Arendrup,et al. Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study , 2015, Antimicrobial Agents and Chemotherapy.
[95] Robin Patel,et al. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[96] T. Welte,et al. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria , 2015, Intensive Care Medicine.
[97] B. Kullberg,et al. Invasive Candidiasis. , 2015, The New England journal of medicine.
[98] Blake W Buchan,et al. Emerging Technologies for the Clinical Microbiology Laboratory , 2014, Clinical Microbiology Reviews.
[99] S. Saint,et al. Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals: 2014 Update , 2014, Infection Control & Hospital Epidemiology.
[100] E. P. Dellinger,et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[101] Jan V Hirschmann,et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[102] Y. Carmeli,et al. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. , 2014, The Journal of antimicrobial chemotherapy.
[103] S. Saint,et al. Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals: 2014 Update , 2014, Infection Control & Hospital Epidemiology.
[104] J. Rello,et al. DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[105] R. Lynfield,et al. Multistate point-prevalence survey of health care-associated infections. , 2014, The New England journal of medicine.
[106] S. Saint,et al. Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infection: an integrative review , 2013, BMJ quality & safety.
[107] Nagler Test. UK Standards for Microbiology Investigations , 2014 .
[108] M. Montagna,et al. Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project) , 2013, Infection.
[109] Howard S. Kim. Daily Sedation Interruption in Mechanically Ventilated Critically Ill Patients Cared for with a Sedation Protocol , 2013 .
[110] Liang-yu Chen,et al. A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study , 2013, BMC Infectious Diseases.
[111] Geoff Bellingan,et al. ‘Matching Michigan’: a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England , 2012, BMJ quality & safety.
[112] Sangeeta Mehta,et al. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. , 2012, JAMA.
[113] L. Leibovici,et al. Diagnostic Accuracy of PCR Alone Compared to Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis: a Systematic Review , 2012, Journal of Clinical Microbiology.
[114] Gilbert GREUB,et al. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. , 2012, FEMS microbiology reviews.
[115] B. Spellberg,et al. Pathogenesis of mucormycosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[116] G. Bloemberg,et al. Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[117] F. V. van Tiel,et al. Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009 , 2011, Emerging infectious diseases.
[118] K. Ho,et al. Meta-Analysis of Randomised Controlled Trials on Daily Sedation Interruption for Critically Ill Adult Patients , 2011, Anaesthesia and intensive care.
[119] Matthew Samore,et al. Intervention to reduce transmission of resistant bacteria in intensive care. , 2011, The New England journal of medicine.
[120] M. Falagas,et al. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[121] J. Marshall,et al. Principles of source control in the management of sepsis. , 2011, Critical care nursing clinics of North America.
[122] Sanjay Saint,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[123] T. Calandra,et al. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia , 2010, Critical care.
[124] S. Tschudin-Sutter,et al. Hand hygiene in the intensive care unit. , 2010, Critical care medicine.
[125] Jordi Rello,et al. A European care bundle for prevention of ventilator-associated pneumonia , 2010, Intensive Care Medicine.
[126] E. P. Dellinger,et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[127] Á. Atallah,et al. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. , 2010, The Cochrane database of systematic reviews.
[128] Richard Beale,et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis , 2010, Intensive Care Medicine.
[129] E. Tacconelli,et al. Screening and isolation for infection control. , 2009, The Journal of hospital infection.
[130] J. Marshall,et al. Principles of source control in the management of sepsis. , 2009, Critical care clinics.
[131] D. Warren,et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[132] Jay Steingrub,et al. International study of the prevalence and outcomes of infection in intensive care units , 2009 .
[133] M. Kristjansson,et al. Risk factors and outcome in ICU‐acquired infections , 2008, Acta anaesthesiologica Scandinavica.
[134] S. Saint,et al. Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[135] Carlene A. Muto,et al. Measures to control and prevent Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[136] G. Bernard,et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial , 2008, The Lancet.
[137] P. Pronovost,et al. An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.
[138] Patchen Dellinger,et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[139] France Gauvin,et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[140] Marin H Kollef,et al. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[141] S. Hugonnet,et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene , 2000, The Lancet.
[142] W. Stamm. Guidelines for prevention of catheter-associated urinary tract infections. , 1975, Annals of internal medicine.